Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Claudia Tamburino"'
Autor:
Marco Barbanti, Giuliano Costa, Paolo Zappulla, Denise Todaro, Andrea Picci, Giulia Rapisarda, Emanuela Di Simone, Rita Sicuso, Sergio Buccheri, Simona Gulino, Gerlando Pilato, Ketty La Spina, Paolo D'Arrigo, Roberto Valvo, Antonino Indelicato, Daniela Giannazzo, Sebastiano Immè, Claudia Tamburino, Martina Patanè, Carmelo Sgroi, Angelo Giuffrida, Danilo Trovato, Ines Paola Monte, Wanda Deste, Piera Capranzano, Davide Capodanno, Corrado Tamburino
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 15 (2018)
Background Long‐term data on durability of currently available transcatheter heart valves are sparse. We sought to assess the incidence of long‐term (8‐year) structural valve dysfunction and bioprosthetic valve failure in a cohort of patients w
Externí odkaz:
https://doaj.org/article/530ef2cb87cd42d4899d26eafd910111
Autor:
Roberto Diletti, Robert-Jan van Geuns, Alexandre Abizaid, Patrick W. Serruys, Piera Capranzano, Carlos M. Campos, Alaide Chieffo, Adriano Caixeta, Antonio L. Bartorelli, Hiroyoshi Kawamoto, Jose de Ribamar Costa, Antonio Colombo, Claudia Tamburino, Cordula Felix, Yoshinobu Onuma, Corrado Tamburino
Publikováno v:
Eurointervention, 15, 623-630
Eurointervention, 15, 7, pp. 623-630
Eurointervention, 15, 7, pp. 623-630
AIMS The aim of this study was to investigate the predictors of long-term adverse clinical events after implantation of the everolimus-eluting Absorb bioresorbable vascular scaffold (BVS). METHODS AND RESULTS We pooled patient-level databases derived
Autor:
Claudia Tamburino, Francesco Bedogni, Marco Barbanti, Arnaldo Poli, Marco Angelillis, Giuseppe Bruschi, Bernhard Reimers, Anna Sonia Petronio, Bruno Merlanti, Luca Testa, Cristina Giannini, F. De Felice, Matteo Montorfano, Claudia Fiorina, Luca Branca
Background Concomitant mitral regurgitation (MR) impaired prognosis in patients undergoing transcatheter aortic valve implantation (TAVI). It has been suggested that the use of first generation self-expandable valve in patients with significant MR is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea7f9ebb8bcea3b4aa3e228b8243e00
http://hdl.handle.net/11568/1125180
http://hdl.handle.net/11568/1125180
Autor:
A Bentivegna, M Frazzetto, Sarah Mangiafico, Giuseppe Castania, Davide Capodanno, Capranzano P, Tatiana Salerno, A Milici, Claudia Tamburino, Grasso C, M. E. Di Salvo, Salvatore Scandura, Andrea Sardone, J De Sanctis, Anna Caggegi
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. Background – Although percutaneous mitral valve repair is an attractive alternative treatment option for patients with severe mitral regurgitation (MR) at high surgical risk, residual MR is co
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
Transcatheter aortic valve implantation (TAVI) is a therapeutic option widely used for the treatment of severe aortic stenosis in the elderly. Careful pre-procedural screening, operator experience, and technological innovations, accounted for a safe,
Autor:
Antonino Indelicato, Daniela Giannazzo, Marco Barbanti, Maria Cristina Portelli, Ketty La Spina, Davide Capodanno, Sebastiano Immè, Gerlando Pilato, Paolo D'Arrigo, Simona Gulino, Wanda Deste, Martina Patanè, Piera Capranzano, Giuliano Costa, Andrea Picci, Denise Todaro, Corrado Tamburino, Emanuela Di Simone, Carmelo Sgroi, Claudia Tamburino
Publikováno v:
Structural Heart. 2:229-234
Background: To assess early and mid-term efficacy of transcatheter aortic valve replacement (TAVR) using the new-generation CoreValve Evolut R (Medtronic Inc., Galway, Ireland).Methods: This is a prospective, single-center study. All consecutive pat
Autor:
Fabrizio Ricci, Carlo Lombardi, Carmelo Grasso, R. De Caterina, Elvira Verrengia, Silvia Gallina, Davide Capodanno, Marco Zimarino, Claudia Tamburino, Jorn Brouwer, C De Innocentiis, Martin J. Swaans
Publikováno v:
European Heart Journal. 40
Background The benefit of percutaneous mitral valve repair with mitraclip (PMVR) in patients with secondary mitral regurgitation (MR) is still debated. Methods In order to compare the outcome of PMVR with optimal medical therapy (OMT) versus OMT alon
Autor:
Bruno Francaviglia, Davide Capodanno, Piera Capranzano, Ina Tamburino C, Giovanni Longo, Claudia Tamburino
Publikováno v:
Catheterization and Cardiovascular Interventions. 88:31-37
Bioresorbable vascular scaffolds (BVS, Absorb, Abbott Vascular, Santa Clara, CA) received the CE mark in October 2011, and were approved by the Food and Drug Administration in July 2016. After their introduction in clinical practice a broad amount of
Autor:
Simona Gulino, Marco Barbanti, Wanda Deste, Sebastiano Immè, Patrizia Aruta, Vera Bottari, Emanuele Benvenuto, Claudia Tamburino, Alessio Di Landro, Daria Liberto, Letizia Santonoceto, Rita Sicuso, Daniele Di Stefano, Denise Todaro, Emanuela Di Simone, Antonino Indelicato, Daniela Giannazzo, Carmelo Sgroi, Corrado Tamburino
Publikováno v:
EuroIntervention. 12:e1031-e1038
AIMS Long-term data on the durability of currently available transcatheter heart valves are limited. We sought to assess four-year clinical and echocardiographic outcomes in patients undergoing transcatheter aortic valve implantation (TAVI) with the
Autor:
Jaya Chandrasekhar, Rainer Hambrecht, P Gao, R Mehran, Efthymios Deliargyris, E Van Belle, Ghada W. Mikhail, Christian Hengstenberg, John G. Webb, David Hildick-Smith, Julian D. Widder, George Dangas, Bravo Investigators, Raban Jeger, Nicolas Dumonteil, Anita W. Asgar, Ulrich Hink, Promodoros Anthopoulos, Thierry Lefèvre, Claudia Tamburino, Axel Linke
Publikováno v:
Catheterization and Cardiovascular Interventions. 89:144-153
Background Women comprise almost 50% of patients undergoing transcatheter aortic valve replacement (TAVR) and previous studies have indicated higher rates of procedural complications and bleeding in women compared to men. It is unknown whether men an